|
The Collagen Connection
Jim English and Hyla Cass, MD
Collagen is the protein that forms connective
fibers in tissues such as skin, ligaments, cartilage, bones and
teeth. Collagen also acts as a kind of intracellular "glue"
that gives support, shape and bulk to blood vessels, bones, and
organs such as the heart, kidneys and liver. Collagen fibers keep
bones and blood vessels strong, and help to anchor our teeth to
our gums. Collagen is also required for the repair of blood vessels,
bruises, and broken bones. As the most abundant protein in the body,
collagen accounts for more mass than all the other proteins put
together.
Vitamin C along with the amino acids proline
and lysine is essential for the formation of healthy collagen.
Many vitamins and minerals act as catalysts to support the manufacture
of proteins. In the case of collagen, however, vitamin C is actually
used up as it combines with two amino acids lysine and proline
to form procollagen. Procollagen is then used to manufacture
one of several types of collagen found in different tissues throughout
the body. There are at least fourteen different types of collagen,
but the most common ones are:
- Type I: Makes up the fibers found in
connective tissues of the skin, bone, teeth, tendons and ligaments.
Type II: Round fibers found in cartilage.
- Type III: Forms connective tissues that
give shape and strength to organs, such as the liver, heart, kidneys,
etc.
- Type IV: Forms sheets that lie between
layers of cells in the blood vessels, muscles, and eye.
Our body is continually manufacturing collagen to maintain and
repair connective tissues lost to daily wear and tear. Without vitamin
C, collagen formation is disrupted, resulting in a wide variety
of problems throughout the body. Scurvy, the disease caused by vitamin
C deficiency, is really a process that disrupts the body's ability
to manufacture collagen and connective tissues. With scurvy, the
body literally falls apart as collagen
is broken down and not replaced. The joints begin to wear down as
tendons shrivel and weaken. The blood vessels crumble and begin
to fall apart, leading to bruising and bleeding as vessels rupture
(hemorrhage) throughout the body. Teeth loosen and fall out as the
gums and the connective tissues holding teeth also begin to erode.
Organs, once held firmly together by connective tissues, also lose
structural strength and begin to fail. In time, the various body
tissues weaken, the immune system and heart give out, leading to
death.
In 1989, the eminent American scientist and two-time Nobel Prize
winner, Linus Pauling, announced a breakthrough in how we view and
treat heart disease. In "A Unified Theory of Human Cardiovascular
Disease," Linus Pauling announced that the deposits of plaque
seen in atherosclerosis were not the cause of heart disease, but
were actually the result of our bodies trying to repair the damage
caused by long-term vitamin C deficiency. In essence, Pauling believed
that heart disease is a form of scurvy, and plaque is the body's
attempt to reinforce and patch weakened blood vessels and arteries
that would otherwise rupture. Pauling also showed that heart disease
can be prevented or treated by taking vitamin C and other supplements.
Pauling based his revolutionary theory on a number of important
scientific findings. First was the discovery that plaque deposits
found in human aortas are made up of a special form of cholesterol
called lipoprotein (a) or Lp(a), not from ordinary LDL cholesterol.
Lp(a) is a special form of LDL cholesterol that forms the thick
sheets of plaque that obstruct arteries.
Another finding central to Pauling's theory was
the observation that plaque deposits are not formed randomly throughout
the circulatory system. This was first reported in the early 1950s
when a Canadian doctor, G. C. Willis, MD, observed that plaque always
forms nearest the heart, where blood vessels and arteries are constantly
being stretched and bent, rather than being spread evenly throughout
the entire cardiovascular system. Willis also noted that plaque
deposits always occur in regions that are exposed to the highest
blood pressures, such as the aorta, where blood is forcefully ejected
from the heart.
In 1985, a team of researchers verified that plaque
only forms in areas of the artery that become damaged. Just as cracks
form in a garden hose that has become weak and worn from constant
bending and high-pressure, cracks form in the lining of the arterial
wall. As these tiny cracks open up they expose strands of the amino
acid lysine (one of the primary components of collagen) to the blood
stream. It is these strands that initially attract Lp(a). Lp(a)
is an especially "sticky" form of cholesterol that is
attracted to lysine. Drawn to the break, Lp(a) begins to collect
and attach to the exposed strands. As Lp(a) covers the lysine strands,
free lysine in the blood is drawn to the growing deposit. Over time,
this process continues as lysine and Lp(a) are both drawn from the
blood to build ever-larger deposits of plaque. This process gradually
reduces the inner diameter of the vessels and restricts its capacity
to carry the blood.
Observing the newly described process of plaque formation, Pauling
recognized a similarity to underlying processes seen in scurvy.
He also saw similarities between human and animal models of atherosclerosis
that pointed to a connection with scurvy. First, cardiovascular
disease does not occur in any of the animals that are able to manufacture
their own vitamin C. Many animals produce large amounts of vitamin
C that are equivalent to human doses ranging from ten to twenty
grams per day. Second, the only animals that produce Lp(a) are those
which, like man, have also lost the ability to produce their own
vitamin C, such as apes and guinea pigs.
Putting all the pieces of the puzzle together,
Pauling suggested that the ability to form plaque is really the
body's attempt to repair damage caused by a long-term deficiency
of vitamin C. He knew that our ancestors lived in tropical regions
where the diet consisted primarily of fruits and vegetables. With
a daily intake estimated to be in the range of several hundred milligrams
to several grams per day, our ancestors easily survived without
the gene required to manufacture vitamin C. Almost unnoticed, this
mutation was passed on to successive generations, and only became
a problem when early humans began to spread to other regions of
the world. In effect, when humankind left the "garden,"
the lack of a reliable and adequate supply of dietary vitamin C
led to scurvy.
Pauling thought that scurvy was one of the greatest
threats to humankind's early survival, and believed that the loss
of blood during times of vitamin C deficiency, particularly during
the Ice Ages, likely brought humans close to the point of extinction.
The core of Pauling's theory is that, over time, the body developed
a repair mechanism that allowed it to cope with the damage caused
by chronic vitamin C deficiency. The repair mechanism is as elegant
as it is simple. When arteries became weak and began to rupture,
the body responded by "gluing" the damaged areas together
with Lp(a) to prevent a slow death from internal bleeding. In essence,
plaque is the body's attempt to patch blood vessels damaged by low-level
scurvy. Accordingly, Pauling believed that conventional "triggers"
of plaque formation, such as homocysteine and oxidized cholesterol,
are actually just additional symptoms of scurvy.
Pauling's theory was unique in that it addressed a fact never explained
by older, mainstream theories. Specifically, Pauling finally explained
why plaque isn't randomly distributed throughout the body, but restricted
to areas of high mechanical stress. A surprising number of animal
studies have been found to support Pauling's theory. Research conducted
with animals that cannot make their own vitamin C found that when
vitamin C levels are reduced, collagen production drops and blood
vessels become thinner and weaker. Additional studies also confirm
that when animals are deprived of vitamin C, their bodies respond
by increasing blood levels of Lp(a) and forming plaque deposits
to strengthen arteries and prevent vessel ruptures.
In addition to taking vitamin C to prevent atherosclerosis, Pauling
recommended a combination of vitamin C and the amino acids lysine
and proline to help remove existing plaque while strengthening weak
and damaged arteries. As mentioned previously, the body produces
collagen from lysine and proline. Pauling reasoned that by increasing
concentrations of lysine and proline in the blood, Lp(a) molecules
would bind with the free lysine, rather than with the lysine strands
exposed by the cracks in blood vessels.
While acute scurvy can be prevented by a mere 10 mg vitamin
C per day, there is no current research showing how much vitamin
C might be required to prevent the atherosclerotic plaques of chronic
scurvy. In his Unified Theory, Linus Pauling often recommended 3,000
to 5,000 mg per day as an effective dose. Anecdotal reports from
patients using the Pauling Therapy indicate that rapid recovery
is frequently the rule, not the exception, allowing many people
to avoid open heart surgery and angioplasty.
| Pauling Therapy for
the
Reversal of Heart Disease
1. Vitamin C: to bowel tolerance
- as much as you can take without diarrhea. For most people
this will be in the range of five to ten grams (5,000-10,000
mg.) each day. Spread this amount into two equal doses 12
hours apart. (Vitamin C prevents further cracking of the blood
vessel wall - the beginning of the disease.)
2. L-Proline: 3 grams twice per day
(acts to release lipoprotein(a) from plaque formation and
prevent further deposition of same).
3. L-Lysine: 3 grams twice each day
(acts to release lipoprotein(a) from plaque formation and
prevent further deposition of same).
4. Co-enzyme Q10: 90-180 mg. twice
per day (strengthens the heart muscle).
5. L-Carnitine: 3 grams twice per
day (also strengthens the heart muscle).
6. Niacin: Decreases production of
lipoprotein(a) in the liver. Inositol hexanicotinate is a
form of niacin which gives less of a problem with flushing
and therefore allows for larger therapeutic doses. Begin with
250 mg. at lunch, 500 mg. at dinner and 500 mg. at bedtime
the first day; then increase gradually over a few days until
you reach four grams per day, or the highest dose under four
grams you can tolerate. Be sure to ask your doctor for liver
enzyme level tests every two months or less to be sure your
liver is able to handle the dose you are taking.
7. Vitamin E: 800-2400 IU per day.
(Inhibits proliferation of smooth muscle cells in the walls
of arteries undergoing the atherosclerotic changes.) |
References
1. Marcoux C; Lussier-Cacan S;
Davignon J; Cohn JS. Association of Lp(a) rather than integrally-bound
apo(a) with triglyceride-rich lipoproteins of human subjects. Biochim
Biophys Acta 1997 Jun 23;1346(3):261-74.
2. Ensenat D, Hassan S, Reyna SV, Schafer AI, Durante W. Transforming
growth factor-b1 stimulates vascular smooth muscle cell L-proline
transport by inducing system A amino acid transporter 2 (SAT2) gene
expression. Biochem. J. (2001) 360, (507-512)
3. White AL; Lanford RE. Cell surface assembly of lipoprotein(a) in
primary cultures of baboon hepatocytes. J Biol Chem 1994 Nov 18;269(46):28716-23.
4. Klezovitch O; Edelstein C; Scanu AM. Evidence that the fibrinogen
binding domain of Apo(a) is outside the lysine binding site of kringle
IV-10: a study involving naturally occurring lysine binding defective
lipoprotein(a) phenotypes. J Clin Invest 1996 Jul 1;98(1):185-91.
5. Boonmark NW; Lou XJ; Yang ZJ; Schwartz K; Zhang JL; Rubin EM; Lawn
RM. Modification of apolipoprotein(a) lysine binding site reduces
atherosclerosis in transgenic mice. J Clin Invest 1997 Aug 1;100(3):558-64.
6. Phillips J; Roberts G; Bolger C; el Baghdady A; Bouchier-Hayes
D; Farrell M; Collins P. Lipoprotein (a): a potential biological marker
for unruptured intracranial aneurysms. Neurosurgery 1997 May;40(5):1112-5;
discussion 1115-7.
7. Stubbs P; Seed M; Moseley D; O'Connor B; Collinson P; Noble M.
A prospective study of the role of lipoprotein(a) in the pathogenesis
of unstable angina. Eur Heart J 1997 Apr;18(4):603-7.
8. Shinozaki K; Kambayashi J; Kawasaki T; Uemura Y; Sakon M; Shiba
E; Shibuya T; Nakamura T; Mori T. The long-term effect of eicosapentaenoic
acid on serum levels of lipoprotein (a) and lipids in patients with
vascular disease. J Atheroscler Thromb 1996;2(2):107-9.
9. McCully KS, Homocysteine metabolism in scurvy, growth and arteriosclerosis.
Nature 1971;231:391-392.
10. Pauling L, Rath M. Pro. Nat. Acad. Sci USA, Vol 87, pp 9388-9390,
Dec 1990.
11. Carr AC, Frei B. Toward a new recommended dietary allowance for
vitamin C based on antioxidant and health effects in humans. American
Journal of Clinical Nutrition 1999;69(6):1086-1107.
12. Simon JA, Hudes ES. Serum ascorbic acid and gallbladder disease
prevalence among US adults: the Third National Health and Nutrition
Examination Survey (NHANES III). Arch Intern Med. 2000;160(7):931-936.
13. Stephen R, Utecht T. Scurvy identified in the emergency department:
a case report. Journal of Emerg Med. 2001;21(3):235-237.
14. Cameron E, Pauling L. Supplemental ascorbate in the supportive
treatment of cancer: Prolongation of survival times in terminal human
cancer. Proc Natl Acad Sci U S A. 1976;73(10):3685-3689. |